Posts in tag

PBS


Consumers will need to be prepared for the changes flowing from the PBS delisting of 17 types of medicines on 1 January 2016, says the PSA. The medicines include products …

Minister for Health Sussan Ley today confirmed the 17 types of common OTC medicines, including paracetamol and aspirin, that will no longer be subsidised as a prescription drug under the …

A Joint Position Paper calling for improvements in the Closing The Gap (CTG) PBS Co-payment measure was signed between the National Aboriginal Community Controlled Health Organisation (NACCHO) and the Pharmacy Guild …

Twenty-seven leading medical associations and health advocacy groups have published an open letter to the Federal Health Minister urging the immediate inclusion of breakthrough hepatitis C cures on the PBS. …

Health Minister Sussan Ley has criticised pharmaceutical companies for dragging their feet on bringing new drugs to the Australian market and prioritising applying to lucrative markets overseas. “Australia has a …

The 2015 PricewaterhouseCoopers survey of the Australian medicines industry provides an important and timely insight into the challenges and opportunities confronting the Australian innovative medicines industry, says Medicines Australia. The …

TGA regulation, price pressure and compliance issues are reducing access to medicines, and reducing industry confidence, a PwC report claims. Challenges and Change—a report on the Australian pharmaceutical industry, released …

The release of the Final Budget Outcomes for 2014‑15 has revealed policy reforms are continuing to put downward pressure on PBS expenditure, says Medicines Australia. The final Budget papers released …

Nearly 3000 Australians with hepatitis C have progressed to severe liver disease in the last year, as thousands continue to wait for affordable access to curative medicines recommended for a …

The latest round of price disclosure related price changes, which will come into effect on 1 October, 2015, have been announced. The chemotherapy drug capecitabine is to see a 52% …

A government subsidy for a biologic to treat vision impairment caused by macular oedema in patients with diabetes or retinal vein occlusion (branch or central) will be available from 1 July.

The number of dates on which the price of PBS-listed medicines can change will increase from three times a year to six times a year, as part of the package …